Which Weight Management Injection Offers Better Value?
Wegovy Cost vs Mounjaro: Key Differences Explained
When comparing Wegovy cost against Mounjaro, the fundamental difference lies in their mechanisms of action and pricing structures. Wegovy contains semaglutide, a GLP-1 receptor agonist, whilst Mounjaro contains tirzepatide, which targets both GIP and GLP-1 receptors. This dual mechanism may influence prescriber choice based on individual patient factors. Wegovy follows a 5-dose escalation from 0.25mg to 2.4mg over 16 weeks, whereas Mounjaro uses a 6-dose escalation from 2.5mg to 15mg over 20 weeks. The cost implications extend beyond initial price, as maintenance therapy represents the long-term investment.
From a practical standpoint, Wegovy offers superior storage flexibility with 6 weeks of room temperature stability compared to Mounjaro's 21-day limit. This difference significantly impacts travel convenience and reduces medication wastage if refrigeration is temporarily unavailable. Both medications require prescription-only access through clinical assessment, but the storage advantage often influences patient preference. EverydayMeds stocks both options, allowing prescribers to recommend based on clinical suitability rather than availability constraints. The wegovy cost structure reflects these practical benefits alongside the established clinical evidence base.
Transparent Wegovy Cost Breakdown vs Mounjaro Pricing
Wegovy cost at EverydayMeds starts with the 0.25mg starter dose at £79.99, progressing to £94.99 for 0.5mg, £99.99 for 1mg, £139.99 for 1.7mg, and £209.99 for the 2.4mg maintenance dose. These prices reflect discount codes applied at checkout: FIRST40 for new customers and DOSE25 for returning patients. Bundle options provide convenience for multi-dose supply, with the Intro Trio (0.25mg, 0.5mg, 1mg) available for £299.99, covering the first 12 weeks of treatment. The Ultimate Stability Trio offers three months of 2.4mg maintenance supply for £649.99, ensuring consistent access without repeated ordering.
Mounjaro pricing follows a different structure due to higher starting doses and distinct escalation pattern. Direct comparison requires understanding that Mounjaro's 2.5mg starting dose represents a different pharmacological approach than Wegovy's 0.25mg initiation. The wegovy cost advantage becomes apparent in the initial months, with lower absolute prices during dose escalation. Both medications qualify for the same discount codes, but the underlying price points differ based on manufacturing costs and licensing agreements. Total treatment costs depend on individual dose tolerance and prescriber recommendations for maintenance therapy.
Clinical Evidence Behind Wegovy Cost Effectiveness
The wegovy cost must be evaluated against clinical outcomes demonstrated in the STEP trial programme. In clinical trials, patients taking Wegovy alongside diet and exercise achieved approximately 15% average weight loss at 68 weeks compared to 2.4% with placebo (Wilding et al., NEJM, 2021). The SELECT trial additionally demonstrated a 20% reduction in major cardiovascular events with semaglutide. These outcomes provide context for understanding the investment in long-term weight management therapy.
Comparative effectiveness data between Wegovy and Mounjaro comes from separate trial programmes with different patient populations and study designs. Both treatments showed substantial weight loss in their respective trials, but direct head-to-head comparison data remains limited. The wegovy cost evaluation should consider that treatment duration typically extends beyond the initial dose escalation period, making maintenance phase pricing particularly relevant for budget planning.
How Wegovy Works: Understanding the GLP-1 Mechanism
Wegovy contains semaglutide, which mimics the natural GLP-1 hormone responsible for regulating blood sugar and appetite. This mechanism works by slowing gastric emptying, promoting satiety after smaller meals, and reducing food cravings through effects on brain appetite centres. The once-weekly injection delivers sustained hormone activity, supporting consistent appetite regulation throughout the week. Unlike oral medications, the subcutaneous injection bypasses digestive breakdown, ensuring reliable absorption and effect. The GLP-1 mechanism has been extensively studied for both diabetes management and weight control, with Wegovy specifically licensed for weight management in combination with reduced-calorie diet and increased physical activity.
Streamlined Wegovy Cost Assessment and Ordering Process
Accessing Wegovy through EverydayMeds begins with a comprehensive 3-minute online clinical assessment covering medical history, current medications, and treatment goals. Our prescribers review applications within 3 working days (24 hours with express service), ensuring clinical suitability before approving treatment. Once approved, next-day delivery maintains cold-chain integrity with temperature-controlled packaging throughout transit. The process eliminates traditional pharmacy visits whilst maintaining full clinical oversight and safety standards. Payment processing includes automatic application of relevant discount codes, with the final wegovy cost clearly displayed before checkout confirmation.
Storage Requirements and Practical Wegovy Cost Considerations
Wegovy requires refrigerated storage at 2-8°C before first use, but offers exceptional flexibility with 6 weeks of room temperature stability below 30°C once removed from refrigeration. The FlexTouch pen design simplifies injection technique with pre-filled, single-use construction requiring no mixing or preparation. Each pen contains 4 weekly doses at the prescribed strength, with clear markings for dose selection and injection tracking. Proper storage maximises medication potency and reduces waste, directly impacting overall wegovy cost effectiveness. The extended room temperature stability provides significant advantage over alternative treatments with shorter temperature tolerance periods.
Wegovy Cost vs Mounjaro: Long-term Value Analysis
Long-term wegovy cost evaluation requires considering maintenance phase requirements and potential treatment duration. Most patients require ongoing therapy to maintain weight loss benefits, with clinical data showing approximately two-thirds weight regain within one year of discontinuation. The 2.4mg maintenance dose represents the ongoing investment, priced at £209.99 per pen providing 4 weeks of treatment. Comparative analysis with Mounjaro must account for different maintenance dose requirements and frequency of dose adjustments based on individual response.
The storage advantage of Wegovy translates to reduced medication waste and greater treatment flexibility, factors that influence overall cost effectiveness beyond simple price comparison. Travel requirements, work schedules, and lifestyle factors may favour the extended room temperature stability. Both treatments require similar clinical monitoring and follow-up assessments, but practical convenience factors can impact long-term adherence and success rates.
Expert Wegovy Cost Guidance from EverydayMeds Clinical Team
Our GPhC-registered clinical team (#9012878) provides comprehensive guidance on treatment selection based on individual clinical factors rather than cost considerations alone. The wegovy cost structure supports flexible payment options and bundle arrangements to suit different financial circumstances and treatment phases. Discount codes FIRST40 and DOSE25 are automatically applied at checkout to ensure transparent pricing without hidden fees or unexpected charges. Both Wegovy and Mounjaro are available through our streamlined service, with prescriber recommendations based on medical suitability and patient preference. Visit https://everydaymeds.co.uk/collections/weight-loss to begin your clinical assessment and receive expert guidance on the most appropriate treatment option for your weight management goals.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
